Dr Saara Kaviany and Dr Blachy J. Dávila Saldaña discuss the overall treatment goals and management strategies for patients with hemophagocytic lymphohistiocytosis (HLH).
Dr Saara Kaviany and Dr Blachy J. Dávila Saldaña discuss the overall treatment goals and management strategies for patients with hemophagocytic lymphohistiocytosis (HLH). The discussion focuses on clinical considerations in HLH management, treatment goals, and factors clinicians may consider when evaluating patients with HLH.
This video features expert clinician discussion and is intended for US healthcare professionals.
Chapters
0:00 - HLH Treatment Goals and Management Overview
5:07 - Primary HLH Treatment Goals: Stabilization, Toxicity Reduction, and HSCT Preparation
10:40 - HSCT in Primary HLH: Treatment Pathway Considerations
18:43 - Initial HLH Treatment and Hyperinflammation Control
24:59 - HLH Treatment Risks and Clinical Considerations
30:01 - Targeted Treatment Approaches in HLH
35:17 - Key Takeaways for HLH Treatment Planning
Follow Us
Presented by Sobi Inc.